Guilin Sanjin Pharmaceutical Co., Ltd.

SZSE:002275.SZ

14.38 (CNY) • At close October 26, 2023
Overview | Financials

Numbers are in millions (except for per share data and ratios) CNY.

202320222021202020192018201720162015201420132012201120102009200820072006
Operating Activities:
Net Income 421.299329.527343.719277.021392.143413.346464.402393.66376.673444.866420.268331.152291.899257.382307.831274.089249.498195.016
Depreciation & Amortization 115.119114.832106.7280.26690.68575.71668.64865.01958.79834.82430.0628.326.74826.30322.09523.80823.72719.704
Deferred Income Tax -1.1322.421-2.3671.6563.8891.243-1.789-1.162-1.232000000000
Stock Based Compensation 30.47865.7760000000000000000
Change In Working Capital -35.75732.821-48.768240.091-22.37742.308-141.40676.883-29.407-75.83-101.192-57.146.13315.15832.584-113.365-114.3223.61
Accounts Receivables 72.954-88.248-66.831108.49393.443-36.527-166.7116.24368.583-59.7-90.251-174.614000000
Inventory -27.2333.669-99.727-18.425-28.00950.348-45.36838.886-39.631.353-43.8850.675-24.704-28.044-12.16411.663-1.754-2.682
Accounts Payables -80.34984.979120.157148.367-91.69927.24472.46222.916-57.482000000000
Other Working Capital 30.4782.421-2.3671.6563.889-8.039-96.03737.99710.223-77.183-57.307-57.77570.83743.20244.748-125.028-112.5686.292
Other Non Cash Items 10.169-16.7098.5710.6137.83420.356-3.8211.288-7.568-7.33-34.9770.238-23.73-13.3550.786.4345.488-0.665
Operating Cash Flow 549.246528.667410.242597.991468.285551.726387.823536.851398.495396.53314.159302.589341.05285.488363.29190.966164.391217.666
Investing Activities:
Investments In Property Plant And Equipment -76.395-62.265-144.091-205.472-226.141-89.965-61.53-65.359-125.015-211.284-312.845-205.634-126.748-98.442-54.681-38.641-17.594-29.158
Acquisitions Net 53.6932.75527.7287.2031.44592.491.565-59.0660.0712.691-21.0510.1040.304000-0.8360.113
Purchases Of Investments -986.574-702.356-1,027-1,355.143-255.5-754.4-1,268.06-851.8-1,003.8-1,083.823-1,595.4-953.35-736.490005.493-12.82
Sales Maturities Of Investments 658.592651.5581,190.3291,070.251269.2961,037.3561,121.941716.2991,155.1361,156.0451,407.677887.095698.8112.1340.2190.1620.2754.363
Other Investing Activites 256.46230.066-193.937275.203-462.665-89.96520.637.01911.22-29.836136.57171.98718.2314.0683.8194.1892.8682.083
Investing Cash Flow -94.222-80.243-146.972-207.957-673.565195.515-185.454-252.90637.612-166.207-385.049-199.798-145.893-82.241-50.643-34.29-9.795-35.421
Financing Activities:
Debt Repayment -77.113-295.603-154.4-104.275-100-100-90-50-50-22.20-71.1-1.1-26.1-328.1-355.1-183-15
Common Stock Issued 0000179.4890000000000000
Common Stock Repurchased 0000-179.489-24.515000000000000
Dividends Paid -411.298-528.812-460.218-132.313-203.881-238.908-240.557-296.571-356.825-326.508-295.588-239.004-100.018-251.224-177.356-227.128-151.599-50.349
Other Financing Activities -10.908183.7288.207169.108-33.82875.485142.07650.7351.30750.4622076.30171,029.578349.73520
Financing Cash Flow -361.568-682.781-319.889-81.899-344.104-263.422-188.481-295.842-355.517-298.246-275.588-233.804-101.118-260.324524.122-232.52817.401-65.349
Other Information:
Effect Of Forex Changes On Cash 0.8658.315-2.711-1.128000.106000-0.0030-00.18200.0290.2010.212
Net Change In Cash 94.32-226.042-59.331307.008-549.384483.81913.994-11.89780.59-67.922-346.482-131.01394.039-56.895836.769-75.823172.198117.109
Cash At End Of Period 783.906689.586915.628974.959667.9511,217.335733.516719.521706.59626690.1791,036.661,167.6731,073.6351,130.53293.761369.584197.386